Pricing Log in Create free account
Friday 6 November 2026 Export EXEL’s income statement to Excel — free account

Exelixis, Inc.

EXEL Healthcare Biotechnology

Exelixis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 6.98% from fiscal 2024.

Revenue
+10.2%
EPS
+22.2%
Free cash flow
−4.83%

Quarter to September 2026, against a year earlier

69.77 1.06 +1.54%
Market cap
$16.8B
P/E
19.9×
Fwd P/E
20.2×
Dividend yield
—
F-score
7/9
Altman Z
12.68
Beneish M
−2.61
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Exelixis, Inc. (EXEL) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Exelixis, Inc. (EXEL) trades at a P/E ratio of 19.9×. Over the past ten years it has ranged from 0.0× (June 2017) to 146× (August 2017); the current reading is higher than 54% of that period. That is above the Biotechnology industry median of 10.3× and below the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 15.2× (18.02%)
FY2024 18.5× (49.49%)
FY2023 36.6× 28.09%
FY2022 28.6× 15.00%
FY2021 24.9× (54.16%)
FY2020 54.2× 226.32%
FY2019 16.6× 94.37%
FY2018 8.6× (85.56%)
FY2017 59.2× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 16.9× 2.39%
Jun 2026 16.5× 20.32%
Mar 2026 13.7× (9.65%)
Dec 2025 15.2× (9.66%)
43 more quarters

Against its own ten years

Low 0.0× High 146×
Ten-year median 18.7×
Current reading's percentile 42

P/E ratio against peers

Company P/E ratio
SMMT Summit Therapeutics PLC compare n/m
BNTX BioNTech SE Sponsored ADR compare n/m
BBIO BridgeBio Pharma, Inc. compare n/m
INSM Insmed, Inc. compare n/m
ALNY Alnylam Pharmaceuticals, Inc. compare 7.9×
ASND Ascendis Pharma A/S compare 18.3×
EXEL Exelixis, Inc. 19.9×
HALO Halozyme Therapeutics, Inc. compare 29.5×
JAZZ Jazz Pharmaceuticals PLC compare 62.6×
Biotechnology industry median 10.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on EXEL